Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Biotron Compound Active Against Resistant HIV

2 May 201317 August 2005 by Karen Mobbs

Biotron Compound Active Against Resistant HIV

Categories 2005
Post navigation
Passing of Professor Peter Gage
Lead HIV Drug Selected to Progress Into Human Trials
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 7 January 2021        Legal Notices and Privacy